ATE471986T1 - Verbesserung der homogenität und sekretion von rekombinanten proteinen in säugetiersystemen - Google Patents
Verbesserung der homogenität und sekretion von rekombinanten proteinen in säugetiersystemenInfo
- Publication number
- ATE471986T1 ATE471986T1 AT01999652T AT01999652T ATE471986T1 AT E471986 T1 ATE471986 T1 AT E471986T1 AT 01999652 T AT01999652 T AT 01999652T AT 01999652 T AT01999652 T AT 01999652T AT E471986 T1 ATE471986 T1 AT E471986T1
- Authority
- AT
- Austria
- Prior art keywords
- interest
- secretion
- homogeneity
- relates
- improvement
- Prior art date
Links
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title abstract 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title abstract 2
- 230000028327 secretion Effects 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 abstract 2
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 abstract 2
- 108010076504 Protein Sorting Signals Proteins 0.000 abstract 2
- 229940028334 follicle stimulating hormone Drugs 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL14011000A IL140110A0 (en) | 2000-12-05 | 2000-12-05 | Improvement of homogeneity and secretion of recombinant proteins in mammalian systems |
| PCT/IL2001/001125 WO2002046430A2 (en) | 2000-12-05 | 2001-12-05 | Improvement of homogeneity and secretion of recombinant proteins in mammalian systems |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE471986T1 true ATE471986T1 (de) | 2010-07-15 |
Family
ID=11074884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01999652T ATE471986T1 (de) | 2000-12-05 | 2001-12-05 | Verbesserung der homogenität und sekretion von rekombinanten proteinen in säugetiersystemen |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20040115775A1 (de) |
| EP (1) | EP1339855B1 (de) |
| JP (1) | JP2004516830A (de) |
| AT (1) | ATE471986T1 (de) |
| AU (2) | AU2002222454B2 (de) |
| CA (1) | CA2429094A1 (de) |
| CY (1) | CY1110670T1 (de) |
| DE (1) | DE60142446D1 (de) |
| DK (1) | DK1339855T3 (de) |
| ES (1) | ES2346956T3 (de) |
| IL (1) | IL140110A0 (de) |
| PT (1) | PT1339855E (de) |
| SI (1) | SI1339855T1 (de) |
| WO (1) | WO2002046430A2 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1897552B1 (de) * | 2003-04-18 | 2009-06-17 | Biogen Idec MA Inc. | Polymerkonjugiertes glycosiliertes Neublastin |
| GB0314856D0 (en) | 2003-06-25 | 2003-07-30 | Unitargeting Res As | Protein expression system |
| US20070141666A1 (en) | 2003-09-26 | 2007-06-21 | Applied Research Systems Ars Holding N.V. | Leader sequences for use in production of proteins |
| US7598059B2 (en) | 2003-10-02 | 2009-10-06 | Biogen Idec Ma Inc. | Neublastin expression constructs |
| CN101043899B (zh) | 2004-08-19 | 2011-03-30 | 比奥根艾迪克Ma公司 | 重折叠转化型生长因子beta家族蛋白 |
| CA2609060C (en) * | 2005-06-03 | 2014-07-15 | Urs Weber | Production of recombinant il-18 binding protein |
| WO2007009082A1 (en) * | 2005-07-12 | 2007-01-18 | Codon Devices, Inc. | Compositions and methods for biocatalytic engineering |
| TWI501774B (zh) | 2006-02-27 | 2015-10-01 | Biogen Idec Inc | 神經性病症之治療 |
| WO2008108344A1 (ja) * | 2007-03-02 | 2008-09-12 | Cellgentech, Inc. | Lcat欠損症の遺伝子治療用細胞並びにこれを産生するのに用いられる複製欠損性レトロウイルスベクター及びプラスミド |
| TWI445544B (zh) | 2007-05-01 | 2014-07-21 | Biogen Idec Inc | 增進血管形成之組合物及方法 |
| TWI488640B (zh) | 2008-04-16 | 2015-06-21 | 菲瑞茵國際中心股份有限公司 | 藥學製劑 |
| WO2010036978A2 (en) | 2008-09-25 | 2010-04-01 | Transgenrx, Inc. | Novel vectors for production of growth hormone |
| WO2010036976A2 (en) | 2008-09-25 | 2010-04-01 | Transgenrx, Inc. | Novel vectors for production of antibodies |
| EP2417263B1 (de) | 2009-04-09 | 2015-09-23 | ProteoVec Holding L.L.C. | Herstellung von proteinen unter verwendung von vektoren auf transposonbasis |
| CA2904146C (en) | 2013-03-08 | 2023-03-21 | Neuclone Biologics Pty Ltd | A cell expression system |
| EP3932947A1 (de) * | 2013-03-14 | 2022-01-05 | Translate Bio MA, Inc. | Verfahren und zusammensetzungen zur abgabe von mrna-codierten antikörpern |
| JP6836999B2 (ja) | 2015-03-24 | 2021-03-03 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California | アデノ随伴ウイルス変異体及びその使用方法 |
| KR20200138334A (ko) | 2018-04-02 | 2020-12-09 | 팩트 파마, 인크. | 펩티드-MHC comPACT |
| CN111304243A (zh) * | 2018-12-12 | 2020-06-19 | 普莱柯生物工程股份有限公司 | 一种高效表达外源蛋白的cho细胞株的构建方法、构建的cho细胞株及其应用 |
| WO2021011841A1 (en) * | 2019-07-18 | 2021-01-21 | Lysogene | Compositions and methods for the treatment of sanfilippo disease and other disorders |
| CN116234814A (zh) * | 2020-08-28 | 2023-06-06 | 江苏恒瑞医药股份有限公司 | 用于降低异源多肽末端异质性的信号肽 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4923805A (en) * | 1983-11-02 | 1990-05-08 | Integrated Genetics, Inc. | Fsh |
| FR2619719B1 (fr) * | 1987-09-01 | 1991-05-10 | Sanofi Sa | Procede d'obtention d'interleukine-2 a partir de cellules eucaryotes, vecteurs necessaires a sa mise en oeuvre et lignees cellulaires hautement productrices |
| US5417970A (en) * | 1988-10-21 | 1995-05-23 | Sanofi | Drugs containing a glycosylated interleukin-2 |
| NZ506214A (en) * | 1996-09-13 | 2002-11-26 | Transkaryotic Therapies Inc | Therapy for alpha-galactosidase A deficiency |
| IL126562A0 (en) * | 1998-10-14 | 1999-08-17 | Interpharm Lab Ltd | Expression and secretion of icil-1 receptor antagonist type ii |
-
2000
- 2000-12-05 IL IL14011000A patent/IL140110A0/xx unknown
-
2001
- 2001-12-05 WO PCT/IL2001/001125 patent/WO2002046430A2/en not_active Ceased
- 2001-12-05 CA CA002429094A patent/CA2429094A1/en not_active Abandoned
- 2001-12-05 DK DK01999652.9T patent/DK1339855T3/da active
- 2001-12-05 ES ES01999652T patent/ES2346956T3/es not_active Expired - Lifetime
- 2001-12-05 EP EP01999652A patent/EP1339855B1/de not_active Expired - Lifetime
- 2001-12-05 DE DE60142446T patent/DE60142446D1/de not_active Expired - Lifetime
- 2001-12-05 JP JP2002548147A patent/JP2004516830A/ja active Pending
- 2001-12-05 AU AU2002222454A patent/AU2002222454B2/en not_active Ceased
- 2001-12-05 SI SI200130972T patent/SI1339855T1/sl unknown
- 2001-12-05 PT PT01999652T patent/PT1339855E/pt unknown
- 2001-12-05 AT AT01999652T patent/ATE471986T1/de active
- 2001-12-05 US US10/432,196 patent/US20040115775A1/en not_active Abandoned
- 2001-12-05 AU AU2245402A patent/AU2245402A/xx active Pending
-
2004
- 2004-06-02 US US10/858,928 patent/US7282352B2/en not_active Expired - Fee Related
-
2010
- 2010-07-20 CY CY20101100677T patent/CY1110670T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002046430A3 (en) | 2003-01-03 |
| US20040115775A1 (en) | 2004-06-17 |
| ES2346956T3 (es) | 2010-10-22 |
| EP1339855A2 (de) | 2003-09-03 |
| AU2002222454B2 (en) | 2007-04-05 |
| AU2245402A (en) | 2002-06-18 |
| JP2004516830A (ja) | 2004-06-10 |
| US7282352B2 (en) | 2007-10-16 |
| IL140110A0 (en) | 2002-02-10 |
| CY1110670T1 (el) | 2015-06-10 |
| WO2002046430A2 (en) | 2002-06-13 |
| US20060234352A1 (en) | 2006-10-19 |
| PT1339855E (pt) | 2010-07-07 |
| DE60142446D1 (de) | 2010-08-05 |
| CA2429094A1 (en) | 2002-06-13 |
| SI1339855T1 (sl) | 2010-08-31 |
| DK1339855T3 (da) | 2010-08-30 |
| EP1339855B1 (de) | 2010-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110670T1 (el) | Βελτιωση της ομοιογενειας και εκκρισης των ανασυνδυασμενων πρωτεϊνων σε συστηματα θηλαστικων | |
| WO2005017149A8 (en) | Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site | |
| NZ232742A (en) | Yeast heterologous protein production method, vectors, dna constructs and proteins so produced and aprotinin (1-58) so produced | |
| ATE49233T1 (de) | Vektoren zur transformation von hefe. | |
| NO308310B1 (no) | Hovedsakelig rent KGF protein og dets anvendelse | |
| DE69128285D1 (de) | Expression rekombinanter polypeptide mit verbesserter möglichkeit zur reinigung | |
| DK0531404T3 (da) | Ubiquitin-specifik protease | |
| Jimenez et al. | Bromocontryphan: post-translational bromination of tryptophan | |
| ATE182901T1 (de) | Für androgen-rezeptor-protein kodierende dna | |
| WO1997037998A3 (en) | Neuropeptide y receptor y5 and nucleic acid sequence | |
| Cool et al. | Identification of a sorting signal for the regulated secretory pathway at the N-terminus of pro-opiomelanocortin | |
| DE69735716D1 (de) | Kappa/mu ähnliche proteintyrosinphosphatase, proteintyrosinphosphatase lambda | |
| DE60137829D1 (de) | Menschliche stra6 polypeptide | |
| Zarreh-Hoshyari-Khah et al. | Bioactivity of recombinant prorelaxin from the marmoset monkey | |
| AR012499A1 (es) | Una secuencia quimerica de acido nucleico que codifica una proteina de fusion, un vector de expresion que comprende dicha secuencia quimerica, una celula huesped transformada que contiene dicho vector, la proteina de fusion obtenida y un metodo in vitro para la preparacion de un polipeptido recombin | |
| Canova-Davis et al. | Transpeptidation during the analytical proteolysis of proteins | |
| ATE317443T1 (de) | N-terminal verlängerte proteine exprimiert in hefe | |
| NO178504C (no) | Fr.måte for fr.stilling av minaktivin,DNA-molekyl,gen,vert,prober,preparat som omfatter prober,reagens for lokalisering og defini. av grenser for tumor i histologiske pröver,samt anvendelse av DNA-molekyl,minaktivin og preparat | |
| DE69733414D1 (de) | Protein tyrosin-phosphatasen von hematopoietischen zellen | |
| EP1427825A4 (de) | Menschliche alpha2-delta4-calciumkanal-untereinheit codierende cdna | |
| PT1241179E (pt) | Proteína humana possuindo actividade antiproliferativa in vitro | |
| DE60033583D1 (de) | Eine mycobacterium tuberculosis kodierende sequenz zur expression von heterologen proteinen | |
| DK1241186T4 (da) | Humant vækststandsende specifikt gen-6 (gas-6) og nukleinsyrer kodende derfor | |
| ATE492640T1 (de) | Loslösendes protein 5 - ucp5 | |
| HUP0001462A2 (en) | Human toll-like receptor proteins, related reagents and methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1339855 Country of ref document: EP |